# NHLRC4

## Overview
NHLRC4 (NHL repeat containing 4) is a gene that encodes a protein integral to the regulation of immune responses, particularly through its role in the inflammasome complex. The protein, characterized by the presence of NHL repeats, is crucial for mediating protein-protein interactions that facilitate its function in the innate immune system. As a component of the inflammasome, NHLRC4 is involved in the activation of caspase-1, leading to the maturation and secretion of pro-inflammatory cytokines such as IL-1β and IL-18, which are essential for initiating inflammatory responses and defending against infections (Peng2019Epigenomewide). The protein's involvement in immune regulation and its potential interactions with various cellular pathways underscore its significance in maintaining immune homeostasis and its potential implications in autoinflammatory diseases and cancer.

## Structure
NHLRC4 (NHL repeat containing 4) is a human gene encoding a protein characterized by the presence of NHL repeats, which are crucial for protein-protein interactions. These NHL repeats contribute significantly to the protein's tertiary structure, allowing it to interact with other proteins effectively. The specific arrangement and folding of these repeats facilitate the formation of a stable structure that is essential for its functional roles in various cellular processes.

The protein may undergo post-translational modifications, such as phosphorylation, which can influence its function and stability. These modifications are critical as they can alter the protein's activity, interactions, and overall stability, thereby impacting its role in cellular mechanisms. The presence of these modifications suggests a level of regulatory control over the protein's function, which may be important for its involvement in cellular processes.

While detailed information on the primary, secondary, and quaternary structures of NHLRC4 is not provided, the emphasis on NHL repeats and post-translational modifications highlights the importance of these features in the protein's structural and functional dynamics. The potential for splice variant isoforms is not mentioned, indicating that further research may be needed to explore this aspect of NHLRC4.

## Function
NHLRC4 (NHL repeat containing 4) is a gene that encodes a protein involved in the regulation of immune responses. The NHLRC4 protein is a component of the inflammasome complex, which plays a critical role in the innate immune system by detecting pathogenic microorganisms and stress signals. It is primarily active in the cytoplasm, where it facilitates the activation of caspase-1. This activation leads to the maturation and secretion of pro-inflammatory cytokines such as IL-1β and IL-18, which are crucial for initiating inflammation and defending against infections (Peng2019Epigenomewide).

In the context of HIV research, NHLRC4 was identified as one of the manually selected non-essential genes that were neither enriched nor depleted in a genome-wide screen using the HIV Dependency Factor (HIVDEP) CRISPR/Cas9 sgRNA library. This suggests that while NHLRC4 may not be directly involved in HIV-1 infection processes, it is considered a non-essential gene in this specific context (Montoya2022A). The role of NHLRC4 in healthy human cells is primarily associated with its function in the inflammasome complex, contributing to the body's defense mechanisms against infections and maintaining immune homeostasis.

## Clinical Significance
Mutations and alterations in the NHLRC4 gene have been associated with various autoinflammatory diseases. These include conditions such as macrophage activation syndrome and familial cold autoinflammatory syndrome, which are characterized by dysregulated immune responses and inflammation. Changes in the expression levels or interactions of NHLRC4 can significantly impact inflammatory responses and the overall function of the immune system.

In the context of cancer, the NHLRC4 gene has been studied for its role in thyroid and breast cancers. In thyroid cancer, particularly in the presence of the BRAF V600E mutation, NHLRC4 shows greater hypomethylation in tumor tissues compared to wild-type patients. This suggests that the methylation status of NHLRC4 is influenced by the BRAF mutation, potentially affecting its role in thyroid cancer (Jasmine2023Association). In breast cancer, NHLRC4 is included in a prognostic risk model that assesses breast cancer prognosis, indicating its potential involvement in cancer progression and patient outcomes (Li2024Integrative).

These findings highlight the clinical significance of NHLRC4 in both inflammatory diseases and cancer, suggesting that it may serve as a potential biomarker or therapeutic target in these conditions.

## Interactions
NHLRC4 is involved in various interactions within the cell, particularly in the context of immune response and cellular signaling pathways. It is known to be part of the inflammasome, a multiprotein complex that plays a crucial role in the immune system by mediating the activation of inflammatory responses. Although specific interactions with nucleic acids are not detailed in the available studies, NHLRC4's involvement in cellular processes suggests it may interact with other proteins that influence inflammation and apoptosis (Montoya2022A; Jasmine2023Association).

In the context of thyroid cancer, NHLRC4 has been observed to exhibit differential methylation patterns, particularly hypomethylation in the presence of the BRAF V600E mutation. This suggests a potential interaction with pathways influenced by this mutation, although direct protein interactions are not specified (Jasmine2023Association). NHLRC4 is also included in studies exploring host dependency factors for HIV-1, indicating its potential role in viral replication processes, although it was not found to be significantly enriched or depleted in genome-wide screens (Montoya2022A). These interactions highlight NHLRC4's involvement in diverse biological processes, although further research is needed to elucidate its specific protein interactions.


## References


1. (Montoya2022A) A Virus-Packageable CRISPR System Identifies Host Dependency Factors Across Multiple HIV-1 Strains. This article has 0 citations.

[2. (Peng2019Epigenomewide) Cheng Peng, Evelien R. Van Meel, Andres Cardenas, Sheryl L. Rifas-Shiman, Abhijeet R. Sonawane, Kimberly R. Glass, Diane R. Gold, Thomas A. Platts-Mills, Xihong Lin, Emily Oken, Marie-France Hivert, Andrea A. Baccarelli, Nicolette W. De Jong, Janine F. Felix, Vincent W. Jaddoe, Liesbeth Duijts, Augusto A. Litonjua, and Dawn L. DeMeo. Epigenome-wide association study reveals methylation pathways associated with childhood allergic sensitization. Epigenetics, 14(5):445–466, March 2019. URL: http://dx.doi.org/10.1080/15592294.2019.1590085, doi:10.1080/15592294.2019.1590085. This article has 42 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/15592294.2019.1590085)

[3. (Li2024Integrative) Yan-Shuang Li and Hong-Chuan Jiang. Integrative analysis of homologous recombination repair patterns unveils prognostic signatures and immunotherapeutic insights in breast cancer. Journal of Applied Genetics, March 2024. URL: http://dx.doi.org/10.1007/s13353-024-00848-1, doi:10.1007/s13353-024-00848-1. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s13353-024-00848-1)

[4. (Jasmine2023Association) Farzana Jasmine, Briseis Aschebrook-Kilfoy, Mohammad M. Rahman, Garrett Zaagman, Raymon H. Grogan, Mohammed Kamal, Habibul Ahsan, and Muhammad G. Kibriya. Association of dna promoter methylation and braf mutation in thyroid cancer. Current Oncology, 30(3):2978–2996, March 2023. URL: http://dx.doi.org/10.3390/curroncol30030227, doi:10.3390/curroncol30030227. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/curroncol30030227)